Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Stereotactic Radiotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00087438
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 59
Not applicableActive Not RecruitingNCT05138900
What this trial is testing

A Pilot Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) in Central Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Roswell Park Cancer Institute 30
Testing effectiveness (Phase 2)Looking for participantsNCT03392233
What this trial is testing

Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite Tumors

Who this might be right for
Breast CancerProstate CancerNon Small Cell Lung Cancer
RenJi Hospital 100
Testing effectiveness (Phase 2)Looking for participantsNCT06718309
What this trial is testing

Chemotherapy Plus Immunotherapy Combined With SBRT as Neoadjuvant Therapy for Patients With Resectable NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
First People's Hospital of Hangzhou 40
Testing effectiveness (Phase 2)UnknownNCT01753414
What this trial is testing

Radical Resection Vs. Ablative Stereotactic Radiotherapy in Patients With Operable Stage I NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Radiation Therapy Oncology Group 44
Not applicableStudy completedNCT03673176
What this trial is testing

Lung Volume Reduction for Severe Emphysema by Stereotactic Ablative Radiation Therapy

Who this might be right for
Emphysema
Stanford University 9
Testing effectiveness (Phase 2)Study completedNCT03383302
What this trial is testing

SBRT With Immunotherapy in Early Stage Non-small Cell Lung Cancer: Tolerability and Lung Effects

Who this might be right for
Non-small Cell Lung Cancer Stage IINon-small Cell Lung Cancer Stage I
Royal Marsden NHS Foundation Trust 36
Not applicableActive Not RecruitingNCT03075072
What this trial is testing

Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized Trial

Who this might be right for
Brain Metastases
Dana-Farber Cancer Institute 196
Large-scale testing (Phase 3)Ended earlyNCT00096265
What this trial is testing

Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Malignant Neoplasm in the BrainRecurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer AJCC v7
National Cancer Institute (NCI) 126
Testing effectiveness (Phase 2)Looking for participantsNCT07304739
What this trial is testing

Furmonertinib Combined With Intrathecal Chemotherapy and Stereotactic Radiotherapy (SRT) for EGFR-Mutated NSCLC Patients With Brain Parenchymal and Leptomeningeal Metastases

Who this might be right for
Non Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT03050554
What this trial is testing

SBRT Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Early Stage Non-Small Cell Lung Cancer
Andrew Sharabi 2
Testing effectiveness (Phase 2)Study completedNCT02407171
What this trial is testing

Evaluating the Combination of MK-3475 and Sterotactic Body Radiotherapy in Patients With Metastatic Melanoma or NSCLC

Who this might be right for
MelanomaLung Cancer
Yale University 61
Not applicableWithdrawnNCT06722885
What this trial is testing

Stereotactic Body Radiotherapy for Lung Lesions With Markerless Tracking (MLT) on the VERO® SBRT System

Who this might be right for
Lung CancerStereotactic Body RadiotherapyLung Diseases+3 more
Universitair Ziekenhuis Brussel
Not applicableLooking for participantsNCT05837767
What this trial is testing

Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

Who this might be right for
Invasive Ductal Breast CarcinomaInvasive Ductal Breast Carcinoma Stage IVLobular Breast Carcinoma+12 more
Memorial Sloan Kettering Cancer Center 26
Large-scale testing (Phase 3)Active Not RecruitingNCT04804644
What this trial is testing

Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability

Who this might be right for
Metastatic Lung Small Cell CarcinomaMetastatic Malignant Neoplasm in the BrainRecurrent Lung Small Cell Carcinoma+1 more
NRG Oncology 152
Not applicableWithdrawnNCT02250378
What this trial is testing

Stereotactic Radiosurgery Followed by Wedge Resection in Treating Patients With Early Stage Peripheral Non-small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerStage IA Non-small Cell Lung CancerStage IB Non-small Cell Lung Cancer
University of Southern California
Testing effectiveness (Phase 2)Study completedNCT04271384
What this trial is testing

Stereotactic Ablative Radiotherapy With Nivolumab for Early-Stage Operable Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage I
Hospital Israelita Albert Einstein 25
Testing effectiveness (Phase 2)Study completedNCT03497767
What this trial is testing

A Randomised Phase II Trial of Osimertinib With or Without SRS for EGFR Mutated NSCLC With Brain Metastases

Who this might be right for
Metastatic Non Small Cell Lung Cancer
Trans Tasman Radiation Oncology Group 40
Testing effectiveness (Phase 2)Study completedNCT02107755
What this trial is testing

Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic Melanoma

Who this might be right for
Liver MetastasesLung MetastasesRecurrent Melanoma+2 more
Ohio State University Comprehensive Cancer Center 8
Not applicableStudy completedNCT01463423
What this trial is testing

Individualized Lung Tumor Stereotactic Ablative Radiotherapy (iSABR)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Stanford University 256
Next Page